Tempest Therapeutics, Inc. (TPST:NASDAQ) closed at $0.382 on November 13, 2026, down 0.29% on the day. The stock trades 96.1% below its 52-week high of $9.75 and 13.3% above its 52-week low of $0.337. Over the past year, it lost 95.9%. Tempest Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, TPST closed higher on 91 days (36%). Its best day was September 16, 2026 (+60.26%) and its worst was November 19, 2025 (-48.59%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 3 times.
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
Find more stocks like TPST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.